10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-011813`
Period End Date	20180331
Filing Date	20180508
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	arwr-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 58 Cash Flow Statement 59 Stockholders Equity 18

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.79M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	87.57M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$67.80K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$16.29K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	87.57M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.79M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$744.25K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$867.36K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$357.99K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.36M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$21.74M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$40.77M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$67.90M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$92.66M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.51M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$19.61M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$20.46M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$127.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$104.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.81M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.13M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.56M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.40M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$918.23K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$1.56M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$695.11K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$216.03K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$208.51K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$18.70M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$9.12M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.93M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.74M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.22M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.33M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.16M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.45M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 87,570,398 and 74,785,426 shares issued and outstanding as of March 31, 2018 and September 30, 2017, respectively	`CommonStockValue`	$167.16K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 87,570,398 and 74,785,426 shares issued and outstanding as of March 31, 2018 and September 30, 2017, respectively	`CommonStockValue`	$179.94K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$514.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$574.96M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$25.27K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$33.23K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-460.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-432.82M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$81.42M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$114.27M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$127.00M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$104.02M	USD	Point-in-time

Income Statement 58 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$4.16M	USD	2 Qtrs
REVENUE	`Revenues`	$8.99M	USD	1 Quarter
REVENUE	`Revenues`	$13.35M	USD	2 Qtrs
REVENUE	`Revenues`	$650.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$24.92M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$26.23M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$12.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$11.44M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.68M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.16M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.09M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.68M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$15.68M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$34.38M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$33.01M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$15.12M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-28.85M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-15.03M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-6.13M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-21.03M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$168.35K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$133.89K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$108.74K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$332.08K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-27.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-18.60K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.46M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.31M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$5.72K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$149.75K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$87.08K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.90M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$764.22K	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.88M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.13M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.08M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.04M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-6.04M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-28.08M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-18.13M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-14.88M	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	2 Qtrs
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.18	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	2 Qtrs
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	73.02M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	79.41M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	74.63M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	84.08M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$154.46K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.56K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.14K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.97K	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-28.09M	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-18.17M	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-5.89M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-14.88M	USD	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-6.04M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-18.13M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-14.88M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-27.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-18.60K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.46M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.17M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$3.55M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.29M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.37M	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$64.39K	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-346.34K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$505.82K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-51.51K	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.23M	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.52M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$17.31M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.70M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.27M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.99M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.92M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-5.42M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-196.43K	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-139.45K	USD	2 Qtrs
NET CASH (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-30.13M	USD	2 Qtrs
NET CASH (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.33M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$513.72K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.65M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.02M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$24.85M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$23.70M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$18.17M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-31.50M	USD	2 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$97.14K	USD	2 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$102.41K	USD	2 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$417.14K	USD	2 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$54.67K	USD	2 Qtrs
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$499.86K	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$56.59M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.69M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$56.93M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.18M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-23.65M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$44.97M	USD	2 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
Interest Paid	`InterestPaid`	$95.54K	USD	2 Qtrs
Interest Paid	`InterestPaid`	$88.54K	USD	2 Qtrs
Income Tax Credits Refunded	`ProceedsFromRefundableIncomeTaxCredits`	$3.64M	USD	2 Qtrs
Income Tax Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs
Income Tax Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Stock issued, price per share	`SharesIssuedPricePerShare`	$5.25	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.55M	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$193.12K	USD	2 Qtrs
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	79,374.00	shares	2 Qtrs
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$666.23K	USD	2 Qtrs
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-54.67K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$154.46K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.56K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.14K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.97K	USD	2 Qtrs
Net loss for the six months ended March 31, 2018	`ProfitLoss`	$-6.04M	USD	1 Quarter
Net loss for the six months ended March 31, 2018	`ProfitLoss`	$-28.08M	USD	2 Qtrs
Net loss for the six months ended March 31, 2018	`ProfitLoss`	$-18.13M	USD	2 Qtrs
Net loss for the six months ended March 31, 2018	`ProfitLoss`	$-14.88M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.